LUDHIANA: QR678® - is a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. The therapy curbs hair fall and increases the thickness, the number and density of existing hair follicles, offering greater hair coverage to the ones with alopecia. There has been a sharp rise in the number of temporary reversible hair loss cases in post-Covid patients due to physical and emotional
stress. Hair loss post covid usually begins two or three months after the patient has recovered from Covid-19. Noticeable hair loss usually starts after an average of about 55 days post-recovery. Hair loss happens due to fever because of infection, diet changes, stress due to isolation and stress related factors. This hair loss is known as telogen effluvium. This condition is a temporary form of hair loss and is often seen in Covid patients because of the shock that the body sustains resulting from fever and other symptoms. Problems such as hair loss are fast emerging as one of the common side-effects of this pandemic; with just 4 sessions of the QR678® therapy, there is an increase in the density of existing hair follicles, offering great coverage to the ones with hair loss. This research study has also been published in the Journal of Cosmetic Dermatology.
Dr.Debraj Shome, Clinical Scientist & Leader, R&D Team, QR678® says ‘’the hair-regrowth treatments available in the market, currently have many limitations; they cannot revive hair beyond a certain stage. QR678® is a process where growth factors are injected in the hair follicles, which not only arrests hair fall but also stimulates hair growth. QR678® is a non-surgical, pain-free and non-invasive procedure and we are happy that the treatment has shown very good results in over 100,000+ patients, all over the world.’’
The therapy is being used by many Bollywood celebrities, as it is non-surgical and being plant based, as such has no side effects. The cost of the QR678® is much cheaper than a traditional hair transplant without the side effects which usually accompany surgical hair transplantation and it is suitable for all age groups and genders.
How the therapy works
Signals passed between the upper and lower layers of skin trigger the growth of hair follicles; The 3 stages of hair follicle development are anagen (growth), catagen (dormancy) and telogen (shedding); Extending the anagen phase helps in hair development and growth factors pass the signal to do just that. Growth factors tell the dermal papilla cells to start growing or trigger the anagen phase & QR678® is a special preparation of those growth factors that send this message across with precision. This process is facilitated by Mesotherapy which is carried out with the patented QR 678 molecules. These molecules are branded development elements, used by little practically pain-free administration into the scalp. Growth of hair calls for 5-8 sessions dispersed 2-3 weeks aside each. Typically 1 ml of solution is inserted per sitting, each sitting requires 15 mins, no medical center stay is needed, and every session costs approximately Rs. 7000.
The QR678® therapy has been awarded the prestigious composition and mechanism of administration patent from the United States of America in 2017 and the Indian FDA gave an approval for commercial manufacturing & sale in March 2019. The therapy is also FDA approved in EU, UK, Kuwait and pending approvals in other countries. A true ‘Made in India’ product, the QR 678® hair growth therapy is available globally through a chain of key doctors, franchisees and distributors, with The Esthetic Clinics® team remaining the inventor and research and development team for the therapy.
Dr. Debraj Shome is Director and Co founder of The Esthetic Clinics. He has been rated amongst the top surgeons in India by multiple agencies. The Esthetic Clinics patients include many international and national celebrities who prefer to opt for facial cosmetic surgery and facial plastic surgery in Mumbai because The Esthetic Clinics has its headquarters there.